[Bleomycin alone and in combination with methotrexate in the treatment of carcinoma of the esophagus (author's transl)].
D000328:Adult; D000368:Aged; D000505:Alopecia / Q000139:chemically induced; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced
D001761:Bleomycin; D008727:Methotrexate
Terapia con bleomicina da sola o in associazione con methotrexate nel carcinoma epidermoide dell'esofago